Colonial Trust Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$74.5K Sell
1,140
-150
-12% -$10.1K 0.01% 322
2026
Q2
$82.6K Sell
1,290
-73
-5% -$4.8K 0.01% 304
2026
Q1
$97K Buy
1,363
+17
+1% +$1.34K 0.01% 274
2025
Q4
$110K Sell
1,346
-45
-3% -$3.51K 0.01% 258
2025
Q3
$104K Buy
1,391
+139
+11% +$10.4K 0.01% 258
2025
Q2
$92.7K Sell
1,252
-135
-10% -$9.4K 0.01% 267
2025
Q1
$112K Hold
1,387
– – 0.01% 255
2024
Q4
$108K Sell
1,387
-121
-8% -$10.3K 0.01% 235
2024
Q3
$142K Sell
1,508
-58
-4% -$4.87K 0.01% 227
2024
Q2
$122K Buy
1,566
+62
+4% +$5.06K 0.01% 228
2024
Q1
$137K Sell
1,504
-254
-14% -$21.1K 0.01% 212
2023
Q4
$136K Buy
1,758
+166
+10% +$11.6K 0.01% 209
2023
Q3
$108K Sell
1,592
-27
-2% -$1.96K 0.01% 235
2023
Q2
$132K Sell
1,619
-154
-9% -$12.3K 0.01% 219
2023
Q1
$145K Buy
+1,773
New +$127K 0.02% 215

Other funds holding GEHC

Colonial Trust Advisors's GEHC Position: Q3 2026 in Review

Colonial Trust Advisors reduced its GE HealthCare (GEHC) stake by 12% in Q3 2026, selling an estimated $10.1K and leaving 1,140 shares worth $74.5K. The position accounts for 0.01% of the portfolio, ranked #322.

Colonial Trust Advisors first reported a position in GEHC in Q1 2023 and has held it in 15 quarters since. The position peaked at $145K in Q1 2023. 783 funds tracked by Wall St. Rank hold GEHC as of Q3 2026.

  • Colonial Trust Advisors held 1,140 shares of GE HealthCare worth $74.5K as of Q3 2026.
  • Colonial Trust Advisors sold 150 GE HealthCare shares in Q3 2026, an estimated $10.1K.
  • GE HealthCare made up 0.01% of Colonial Trust Advisors's portfolio in Q3 2026, its #322 holding.
  • Colonial Trust Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 15 quarters since.
  • Colonial Trust Advisors's GE HealthCare position peaked at $145K in Q1 2023.
  • 783 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2026.

Based on Colonial Trust Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.